15 November 2022 : Clinical Research
Suppression of Tumorigenicity 2 Pro-Inflammatory Biomarker Linking Diabetes Mellitus and Periodontitis: A Pilot Study
Paladugu Devi Navya1CDF*, Gurumoorthy Kaarthikeyan1CEF, Selva Raj J.2BCDE, Ahmed Alamoudi3AEF, Maha A. Bahammam45CEF, Bassam Zidane6BDE, Hammam Ahmed BahammamDOI: 10.12659/MSM.938218
Med Sci Monit 2022; 28:e938218
Table 3 Comparison of suppression of tumorigenicity 2 (ST2) levels in gingival crevicular fluid (GCF) by sex and group.
| Serial no. | Sex | Group | Mean | P value |
|---|---|---|---|---|
| 1 | Male | 1 | 211.02 | 0.098 (NS) |
| 2 | 471.10 | |||
| 3 | 566.93 | |||
| 2 | Female | 1 | 315.52 | 0.078 (NS) |
| 2 | 423.38 | |||
| 3 | 550.80 | |||
| Group 1, healthy; group 2, periodontitis; group 3, periodontitis with diabetes mellitus. NS – not significant. When the value is more than 0.05, there is no statistical difference between the sex and ST2 expression. | ||||






